The importance of leukotrienes in mast cell-mediated Toxoplasma gondii cytotoxicity

Journal of Infectious Diseases

Volumn 177, Issue 5, 1998, Pages 1437-1443

  Henderson Jr , William R ^a   Chi, Emil Y ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 [3 TERT BUTYLTHIO 1 (4 CHLOROBENZYL) 5 ISOPROPYL 2 INDOLYL] 2,2 DIMETHYLPROPIONIC ACID; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; INDOMETACIN; LEUKOTRIENE; LEUKOTRIENE B4; LIPOXYGENASE INHIBITOR; N [1 (4 BENZYLOXYPHENYL)ETHYL]ACETOHYDROXAMIC ACID; REACTIVE OXYGEN METABOLITE;

ANIMAL CELL; ARACHIDONIC ACID METABOLISM; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; HOST RESISTANCE; INFLAMMATION; MALE; MAST CELL; NONHUMAN; PRIORITY JOURNAL; RAT; TOXOPLASMA GONDII; TOXOPLASMOSIS;

EID: 17344372970     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517833     Document Type: Article

References (2)

1. Yong EC, Chi EY, Henderson WR Jr. Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon γ-induced antitoxoplasma activity. J Exp Med 1994;180:1637-48.
2. Wilson CB, Remington JS. Activity of human blood leukocytes against Toxoplasma gondii. J Infect Dis 1979;140:890-5.